Celance® (pergolide mesilate)
This section provides a summary of the drug information for Celance® (pergolide mesilate).
If you have any further questions about your PD medication, or other aspects of your PD treatment, you should discuss these with your doctor or other healthcare professional.
Pergolide is an ergoline-based dopamine receptor agonist used for the treatment of Parkinson's disease.
If treatment with a dopamine agonist is being considered, pergolide mesilate is indicated as second line therapy in patients who are intolerant or fail treatment with a non-ergot compound, as monotherapy, or as adjunctive treatment to levodopa in the management of the signs and symptoms of Parkinson's disease.
Product information downloads
The information on this pageprintout is a general summary of the Celance® medication product.
Please click on the links below to download more detailed information on the specific Celance® medication, its handling and use. Links go to the electronic Medicines Compendium (eMC) website.
Further detailed information on the Celance® medication, its handling and use can be downloaded via the electronic Medicines Compendium (eMC) website (http://emc.medicines.org.uk/):
Patient Information Leaflets (PIL)
Summary of Product Characteristics (SPC)
Please note that SPCs are designed for healthcare professionals.
Celance® (pergolide mesilate) is a trademark of Eli Lilly and Company.